Osaka, Japan, April 5, 2024 - Ono Pharmaceutical Co., Ltd. announced that it has decided changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at the.
ONO PHARMA Announces Enrollment Is Complete For The First Arm Of The PROSPECT Study Of Tirabrutinib In U.S. Patients With Relapsed Or Refractory PCNSL menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ ONO Pharmaceuticals, Co., Ltd. today announced it has completed target patient enrollment of the first arm (Part A) of the PROSPECT Study, a.
/PRNewswire/ ONO PHARMA USA today announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco, to award each organization.
ONO PHARMA USA's Tirabrutinib Receives Orphan Drug Designation from the FDA for the Treatment of Primary Central Nervous System Lymphoma streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.